Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Adastra Holdings Ltd C.XTRX

Alternate Symbol(s):  XTXXF

Adastra Holdings Ltd. is a Canada-based company, which is engaged in the supply and manufacturing of ethnobotanical and cannabis products. The Company serves medical markets and is engaged in therapeutic applications. The Company’s Phyto Extractions and Endgame Extracts brands distribute cannabis concentrate products through retailers at approximately 2,000 locations across Canada. As a Health Canada licensed facility, it specializes in extraction, distillation and manufacturing of a range of cannabis-derived products. It partners with healthcare professionals and practitioners within the regulated environment to create products suitable for the medical cannabis market. Its subsidiaries include Adastra Labs Holdings (2019) Ltd., Adastra Labs Inc., 1178562 B.C. Ltd., Adastra Brands Inc., Chemia Analytics Inc., 1225140 B.C. Ltd and 1204581 B.C. Ltd.


CSE:XTRX - Post by User

Post by Betteryear2on Dec 02, 2021 5:17pm
187 Views
Post# 34192283

The Power Play by the Market Herald Releases New Interviews

The Power Play by the Market Herald Releases New Interviews

(Sponsored)
Adastra Holdings has filed its consolidated financial statements and related MD&A for the three and nine months ended September 30, 2021, and 2020. Revenue of approximately $1.8 million compared to approximately $1.2 million in Q2 2021. Gross profit of approximately $934,000 in Q3 2021 nearly doubled from Q2 2021. Net loss decreased to approximately $208,000 compared to approximately $510,000 in Q2 2021. CEO Michael Forbes sat down with Caroline Egan to discuss the results.

For the full interview with Michael Forbes and to learn more about Adastra's Q3 results, click here.

<< Previous
Bullboard Posts
Next >>